Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Low molecular weight heparins versus unfractionated heparin for thromboprophylaxis in surgery, cancer and general medicine: a review of the cost-effectiveness and safety. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2013 Authors' conclusions The evidence from Canadian settings supports the cost-effectiveness of LMWH compared to UFH in medical patients. In terms of HIT or bleeding risk, LMWH was superior to UFH in patients following surgery, but similar or superior to UFH in general medical patients. The results of the findings should be interpreted with caution due to the limitations of methodological quality and various heterogeneities in dosing regimens, time horizon, study perspective and assumptions. Indexing Status Subject indexing assigned by CRD MeSH Heparin; Heparin, Low-Molecular-Weight; Humans; Venous Thrombosis Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000130 Date abstract record published 24/01/2014 |